PHARMATECA » №s5-14 / 2014

A.Yu. Kochish (1), O.M. Lesnyak (2), S.N. Ivanov (1), I.Yu. Silidi (3) FIRST EXPERIENCE OF ORGANIZATION OF SECONDARY PREVENTION OF REPEATED OSTEOPOROTIC FRACTURES WITHIN THE "PROMETHEUS" PROGRAMME OF RUSSIAN ASSOCIATION ON OSTEOPOROSIS IN SAINT PETERSBURG	12-17
E.V. Biryukova POTENTIALS FOR THE USE OF ZOLENDRONATE IN THE TREATMENT OF OSTEOPOROSIS	18-23
A.Yu.Kochish, MD, S.N. Ivanov COMPARATIVE EVALUATION OF THE EFFECTIVENESS OF DOMESTIC GENERICS AND ORIGINAL DRUG OF ZOLEDRONIC ACID IN PATIENTS WITH LOW-ENERGY VERTEBRAL FRACTURES AND POSTMENOPAUSAL OSTEOPOROSIS	24-29
E.V. Doskina DIABETES MELLITUS AND OSTEOPOROSIS. ANALYSIS OF COMBINED APPROACH TO THE TREATMENT	30-33
I.V. Menshikova SECONDARY OSTEOPOROSIS IN RHEUMATIC DISEASES	34-38
Yu.A. Safonova (1, 2), E.G. Zotkin (1, 2), E.N.Kosulnikova (2) FALLS AS GERIATRIC SYNDROME AND METHODS FOR THEIR PREVENTION	40-43
O.V. Yakushevskaya OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN	44-47